Cargando…

Conditions Associated with Circulating Tumor-Associated Folate Receptor 1 Protein in Healthy Men and Women

BACKGROUND: Serum concentrations of the tumor-associated folate receptor 1 (FOLR1) protein may be a marker for early cancer detection, yet concentrations have also been detected in cancer-free women. We investigated the conditions associated with circulating FOLR1 protein in healthy individuals and...

Descripción completa

Detalles Bibliográficos
Autores principales: Kelemen, Linda E., Brenton, James D., Parkinson, Christine, C. Whitaker, Hayley, Piskorz, Anna M., Csizmadi, Ilona, Robson, Paula J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014514/
https://www.ncbi.nlm.nih.gov/pubmed/24810481
http://dx.doi.org/10.1371/journal.pone.0096542
_version_ 1782315189188689920
author Kelemen, Linda E.
Brenton, James D.
Parkinson, Christine
C. Whitaker, Hayley
Piskorz, Anna M.
Csizmadi, Ilona
Robson, Paula J.
author_facet Kelemen, Linda E.
Brenton, James D.
Parkinson, Christine
C. Whitaker, Hayley
Piskorz, Anna M.
Csizmadi, Ilona
Robson, Paula J.
author_sort Kelemen, Linda E.
collection PubMed
description BACKGROUND: Serum concentrations of the tumor-associated folate receptor 1 (FOLR1) protein may be a marker for early cancer detection, yet concentrations have also been detected in cancer-free women. We investigated the conditions associated with circulating FOLR1 protein in healthy individuals and sought to clarify the range of normal serum values. METHODS: Sera of cancer-free men and women (N = 60) enrolled in a population-based cohort study in Alberta, Canada were analyzed for FOLR1 protein using an electrochemical luminescence immunoassay. Dietary, lifestyle, medical and reproductive history information was collected by questionnaires. Differences in serum FOLR1 concentrations between groups were assessed by non-parametric tests, and predictors of serum FOLR1 concentrations were estimated using multivariable linear regression. RESULTS: Median serum FOLR1 concentration was higher in women (491 pg/ml, range = 327–693 pg/ml) than in men (404 pg/ml, range = 340–682 pg/ml), P = 0.001. FOLR1 concentration was also positively associated with vitamin A intake (P = 0.02), and showed positive trends with age and with oral contraceptive hormone use among women and an inverse trend with body mass index. All variables examined explained almost half of the variation in serum FOLR1 (model R(2) = 0.44, P = 0.04); however, the retention of gender (P = 0.003) and vitamin A intake (P = 0.03) together explained 20% (P = 0.001) of serum FOLR1 variation. No other predictor was significant at P<0.05. CONCLUSIONS: The positive association between serum FOLR1 concentration and female gender independent of an age effect suggests caution against statements to exploit serum FOLR1 for early cancer detection without further understanding the biological underpinnings of these observations. Serum FOLR1 concentrations may be influenced by the steroid retinoic acid (vitamin A) but do not appear to be associated with folate nutritional status. These findings require confirmation in larger independent studies.
format Online
Article
Text
id pubmed-4014514
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-40145142014-05-14 Conditions Associated with Circulating Tumor-Associated Folate Receptor 1 Protein in Healthy Men and Women Kelemen, Linda E. Brenton, James D. Parkinson, Christine C. Whitaker, Hayley Piskorz, Anna M. Csizmadi, Ilona Robson, Paula J. PLoS One Research Article BACKGROUND: Serum concentrations of the tumor-associated folate receptor 1 (FOLR1) protein may be a marker for early cancer detection, yet concentrations have also been detected in cancer-free women. We investigated the conditions associated with circulating FOLR1 protein in healthy individuals and sought to clarify the range of normal serum values. METHODS: Sera of cancer-free men and women (N = 60) enrolled in a population-based cohort study in Alberta, Canada were analyzed for FOLR1 protein using an electrochemical luminescence immunoassay. Dietary, lifestyle, medical and reproductive history information was collected by questionnaires. Differences in serum FOLR1 concentrations between groups were assessed by non-parametric tests, and predictors of serum FOLR1 concentrations were estimated using multivariable linear regression. RESULTS: Median serum FOLR1 concentration was higher in women (491 pg/ml, range = 327–693 pg/ml) than in men (404 pg/ml, range = 340–682 pg/ml), P = 0.001. FOLR1 concentration was also positively associated with vitamin A intake (P = 0.02), and showed positive trends with age and with oral contraceptive hormone use among women and an inverse trend with body mass index. All variables examined explained almost half of the variation in serum FOLR1 (model R(2) = 0.44, P = 0.04); however, the retention of gender (P = 0.003) and vitamin A intake (P = 0.03) together explained 20% (P = 0.001) of serum FOLR1 variation. No other predictor was significant at P<0.05. CONCLUSIONS: The positive association between serum FOLR1 concentration and female gender independent of an age effect suggests caution against statements to exploit serum FOLR1 for early cancer detection without further understanding the biological underpinnings of these observations. Serum FOLR1 concentrations may be influenced by the steroid retinoic acid (vitamin A) but do not appear to be associated with folate nutritional status. These findings require confirmation in larger independent studies. Public Library of Science 2014-05-08 /pmc/articles/PMC4014514/ /pubmed/24810481 http://dx.doi.org/10.1371/journal.pone.0096542 Text en © 2014 Kelemen et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Kelemen, Linda E.
Brenton, James D.
Parkinson, Christine
C. Whitaker, Hayley
Piskorz, Anna M.
Csizmadi, Ilona
Robson, Paula J.
Conditions Associated with Circulating Tumor-Associated Folate Receptor 1 Protein in Healthy Men and Women
title Conditions Associated with Circulating Tumor-Associated Folate Receptor 1 Protein in Healthy Men and Women
title_full Conditions Associated with Circulating Tumor-Associated Folate Receptor 1 Protein in Healthy Men and Women
title_fullStr Conditions Associated with Circulating Tumor-Associated Folate Receptor 1 Protein in Healthy Men and Women
title_full_unstemmed Conditions Associated with Circulating Tumor-Associated Folate Receptor 1 Protein in Healthy Men and Women
title_short Conditions Associated with Circulating Tumor-Associated Folate Receptor 1 Protein in Healthy Men and Women
title_sort conditions associated with circulating tumor-associated folate receptor 1 protein in healthy men and women
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014514/
https://www.ncbi.nlm.nih.gov/pubmed/24810481
http://dx.doi.org/10.1371/journal.pone.0096542
work_keys_str_mv AT kelemenlindae conditionsassociatedwithcirculatingtumorassociatedfolatereceptor1proteininhealthymenandwomen
AT brentonjamesd conditionsassociatedwithcirculatingtumorassociatedfolatereceptor1proteininhealthymenandwomen
AT parkinsonchristine conditionsassociatedwithcirculatingtumorassociatedfolatereceptor1proteininhealthymenandwomen
AT cwhitakerhayley conditionsassociatedwithcirculatingtumorassociatedfolatereceptor1proteininhealthymenandwomen
AT piskorzannam conditionsassociatedwithcirculatingtumorassociatedfolatereceptor1proteininhealthymenandwomen
AT csizmadiilona conditionsassociatedwithcirculatingtumorassociatedfolatereceptor1proteininhealthymenandwomen
AT robsonpaulaj conditionsassociatedwithcirculatingtumorassociatedfolatereceptor1proteininhealthymenandwomen